Evogene Ltd. announced that Mr. Nir Arbel, the Company?s Chief Product Officer, requested to step down from his position as CPO, due to relocation. Mr. Arbel will remain in office through August 15, 2024, while a search for a replacement is being conducted.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
229.3 ILa | 0.00% |
|
-6.18% | -23.52% |
Jun. 20 | Nir Arbel Steps Down as Chief Product Officer of Evogene Ltd | CI |
May. 23 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.52% | 32.21M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- EVGN Stock
- News Evogene Ltd.
- Nir Arbel Steps Down as Chief Product Officer of Evogene Ltd